Stevens-Johnson syndrome in children.
Ramien ML.
Curr Opin Pediatr. 2022 Aug 1;34(4):341-348. doi: 10.1097/MOP.0000000000001146.
Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A, Abe R.
F1000Res. 2020 Jun 16;9:F1000 Faculty Rev-612. doi: 10.12688/f1000research.24748.1. eCollection 2020.
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
Meledathu S, Gordon M, Thornton M, Ashinoff R.
J Drugs Dermatol. 2023 Nov 1;22(11):e24-e28. doi: 10.36849/JDD.6999.
Stevens-Johnson syndrome.
Bakshi SS.
Intern Emerg Med. 2019 Mar;14(2):323-324. doi: 10.1007/s11739-018-1981-0. Epub 2018 Nov 8.
Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Liotti L, Caimmi S, Bottau P, Bernardini R, Cardinale F, Saretta F, Mori F, Crisafulli G, Franceschini F, Caffarelli C.
Acta Biomed. 2019 Jan 29;90(3-S):52-60. doi: 10.23750/abm.v90i3-S.8165.
Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lian BS, Lee HY.
Expert Opin Drug Saf. 2022 Aug;21(8):1039-1046. doi: 10.1080/14740338.2022.2106367. Epub 2022 Aug 1.
[Stevens-Johnson syndrome].
Stadler PC, Clanner-Engelshofen BM, Oppel EM, Summer B, Kerl-French K, Flaig MJ, French LE, Seegräber M.
Dermatologie (Heidelb). 2024 Oct;75(Suppl 1):2-4. doi: 10.1007/s00105-024-05361-4. Epub 2024 Jun 7.
Stevens-Johnson syndrome.
Araujo OE, Flowers FP.
J Emerg Med. 1984;2(2):129-35. doi: 10.1016/0736-4679(84)90332-9.
Stevens-Johnson syndrome.
Coster DJ.
Dev Ophthalmol. 1997;28:24-31. doi: 10.1159/000060696.
Stevens-Johnson syndrome/toxic epidermal necrolysis: initial assessment.
Creamer D, Lumb T, Tibbles CD, Lee HY.
BMJ. 2024 Sep 13;386:e079986. doi: 10.1136/bmj-2024-079986.
